Preferable II

Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors

Latest news

14/03/2024 - News
4th Consortium Meeting in Stockholm
On the 14th and 15th of March, our consortium came together in Stockholm to discuss the progression of the PREFERABLE-II project.
07/09/2023 - News
3rd Consortium Meeting in Hannover
During our third consortium meeting in Hannover we further progressed with designing and planning for the implementation of the exercise intervention.
More news

Latest twitter / X

You are invited to the PREFERABLE II
Launch Event in the European Parliament: "The importance of exercise for people living with or beyond cancer" April 26th: https://t.co/4SWjs2KxGI
We are happy to announce that our PREFERABLE-II website is live now! Go and have a look at https://t.co/nKY93sbbqi #HorizonEurope #ExerciseOncology
The PREFERABLE II project kicked off November 2022. Clinicians & researchers from around Europe & Australia are excited to start this project on personalized and live-remote exercise for cancer patients to improve supportive care. Follow this feed for updates & more information! https://t.co/2NJ5zbgY3T PREFERABLE_II photo
More twitter

Collaboration

PREFERABLE II consists of an international consortium of twelve academic partners, one cutting edge game development and software engineering SME, an academic clinical research organisation and one European patient organisation (European Cancer Patient Coalition). The partners are from seven countries: the Netherlands, Germany, Sweden, Portugal, Spain, UK and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.